Revvityブログ
発見から治療までのイノベーションを促進
Latest
From policy to practice: what FDA's 2025 direction means for your precision medicine pipeline.
Cell and Gene Therapy
December 8, 2025 - 5 min read
NGS
Functional characterization of microbial communities through Whole Genome Sequencing.
September 20, 2024 -
2 min read
Small Molecule Drug Discovery
Optimizing the efficiency and reliability of cell isolation and analysis techniques.
September 19, 2024 -
1 min read
Cancer
Recommendations from the AML MRD advisory board and the utility of Mimix Reference Standards in AML research.
September 17, 2024 -
4 min read
Cell and Gene Therapy, Biologics, Cancer
How to count cells using a hemocytometer.
September 13, 2024 -
1 min read
Automation
Speeding up sample prep TAT from tough research biospecimens
September 3, 2024 -
2 min read
Precision Medicine, Biomarker Detection, NGS
Single-cell RNA and protein sequencing as a robust tool for multisite biomarker detection.
August 21, 2024 -
2 min read
NGS
Unraveling the power of unique molecular identifiers in cancer research.
August 16, 2024 -
2 min read
NGS
Challenges in analyzing data with UMI-UDIs in next-generation sequencing.
August 12, 2024 -
2 min read
Physiological Model Solutions, Automation
Partnering with purpose: collaboration with Australian Organoid Facility.
August 9, 2024 -
3 min read
Automation
How to leverage automation of tissue homogenization to address sample prep challenges in drug discovery & development.
August 8, 2024 -
2 min read
